A retrospective analysis firstly revealed that FGF23 was significantly and independently associated with unstable plaques in patients with T2DM who underwent carotid endarterectomy [19], and similar results were also found in African-American T2DM patients without end-stage renal disease [20]. This evidence concerns the gene FGF23 and chronic kidney disease.